Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Model Parameters for Applying the Retinol Isotope Dilution (RID) Method in Preschool Nigerian Children Living in an Area With a High Malaria Burden

NCT02996513 is registered in ClinicalTrials.gov with Wageningen University as lead sponsor.

NCT NCT02996513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02996513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Model Parameters for Applying the Retinol Isotope Dilution (RID) Method in Preschool Nigerian Children Living in an Area With a High Malaria Burden
Lead sponsor
Wageningen University
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2016
Completion date
June 30, 2017
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation, malaria, vitamin a deficiency